iShares U.S. Pharmaceuticals ETF $IHE Stock: Raleigh Capital Management Inc. Grows Holdings

Raleigh Capital Management Inc. lifted its stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 1,723.4% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 7,093 shares of the company’s stock after acquiring an additional 6,704 shares during the period. Raleigh Capital Management Inc.’s holdings in iShares U.S. Pharmaceuticals ETF were worth $713,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Sunbelt Securities Inc. grew its holdings in iShares U.S. Pharmaceuticals ETF by 14.3% in the first quarter. Sunbelt Securities Inc. now owns 960 shares of the company’s stock worth $83,000 after purchasing an additional 120 shares during the period. Root Financial Partners LLC raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 36.5% during the first quarter. Root Financial Partners LLC now owns 696 shares of the company’s stock valued at $60,000 after purchasing an additional 186 shares during the period. Corient Private Wealth LLC raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 3.1% during the fourth quarter. Corient Private Wealth LLC now owns 6,506 shares of the company’s stock valued at $552,000 after purchasing an additional 198 shares during the period. Balance Wealth Partners LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the third quarter valued at about $42,000. Finally, NewEdge Advisors LLC boosted its position in shares of iShares U.S. Pharmaceuticals ETF by 45.1% during the 1st quarter. NewEdge Advisors LLC now owns 1,397 shares of the company’s stock worth $121,000 after purchasing an additional 434 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Price Performance

IHE stock opened at $107.61 on Friday. The company’s 50-day moving average is $102.41 and its 200-day moving average is $94.74. The stock has a market capitalization of $1.61 billion, a PE ratio of 17.75 and a beta of 0.47. iShares U.S. Pharmaceuticals ETF has a 1 year low of $74.93 and a 1 year high of $109.43.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.